Advantage Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $11K | Sell |
300
-1,000
| -77% | -$36.7K | 0.01% | 628 |
|
|
2019
Q2 | $35K | Hold |
1,300
| – | – | 0.03% | 414 |
|
|
2019
Q1 | $35K | Hold |
1,300
| – | – | 0.03% | 415 |
|
|
2018
Q4 | $21K | Hold |
1,300
| – | – | 0.02% | 497 |
|
|
2018
Q3 | $27K | Buy |
1,300
+900
| +225% | +$18.7K | 0.02% | 517 |
|
|
2018
Q2 | $6K | Sell |
400
-1,550
| -79% | -$23.3K | ﹤0.01% | 724 |
|
|
2018
Q1 | $44K | Buy |
1,950
+256
| +15% | +$5.78K | 0.02% | 402 |
|
|
2017
Q4 | $51K | Buy |
1,694
+283
| +20% | +$8.52K | 0.02% | 390 |
|
|
2017
Q3 | $53K | Sell |
1,411
-100
| -7% | -$3.76K | 0.02% | 380 |
|
|
2017
Q2 | $42K | Buy |
1,511
+506
| +50% | +$14.1K | 0.01% | 416 |
|
|
2017
Q1 | $35K | Buy |
1,005
+150
| +18% | +$5.22K | 0.01% | 430 |
|
|
2016
Q4 | $25K | Buy |
855
+400
| +88% | +$11.7K | 0.01% | 466 |
|
|
2016
Q3 | $14K | Buy |
455
+154
| +51% | +$4.74K | 0.01% | 556 |
|
|
2016
Q2 | $10K | Buy |
301
+1
| +0.3% | +$33 | ﹤0.01% | 582 |
|
|
2016
Q1 | $8K | Buy |
+300
| New | +$8K | ﹤0.01% | 586 |
|